image courtesy of City of Hope

Sangeeta Bardhan Cook is the executive director, business innovation, at City of Hope. She joins us on Talking Tech Transfer to discuss the unique aspects of commercialisation at a hospital with a focus on cancer, diabetes and other life-threatening diseases and what it means to be surrounded by patients who often have nowhere else left to turn.

She discusses the importance of City of Hope having its own GMP manufacturing facility, how the impatience of researchers to help patients is driving an entrepreneurial culture and why even far-away Australia isn’t out of the question for IPOs.

Cook also reveals how one particular treatment was so impactful it made her cry and why deathstalker scorpion venom may sound like a wild concept to base a cancer therapy on, but is already becoming a reality thanks to Chimeric Therapeutics.

Subscribe